SCHEMBL7874596

SCHEMBL7874596

COCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)CCc2ccccc2)cn1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GABRA5 P31644 3/20 0.44
OPRM1 P35372 4/20 0.43
OPRD1 P41143 4/20 0.43
OPRK1 P41145 2/20 0.43
EPHX2 P34913 1/20 0.41
GAA P10253 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871596 0.94 GABRA5 (0.45) P4HTMNPC1RAB9ASMN1; SMN2GABRA5
SCHEMBL7869446 0.93 GABRA5 (0.45) P4HTMNPC1RAB9ASMN1; SMN2GABRA5
SCHEMBL7862679 0.91 P4HTM (0.56) P4HTMNPC1RAB9ASMN1; SMN2GABRA5
SCHEMBL7871626 0.90 GABRA5 (0.46) GABRA5OPRM1OPRD1OPRK1EPHX2
SCHEMBL7862742 0.90 KMT2A (0.51) P4HTMNPC1RAB9ASMN1; SMN2OPRM1
SCHEMBL7862809 0.89 GABRA5 (0.43) P4HTMNPC1RAB9ASMN1; SMN2GABRA5
SCHEMBL8868785 0.86 P4HTM (0.55) P4HTMNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL9574736 0.86 GABRA5 (0.50) GABRA5
SCHEMBL9018045 0.85 P4HTM (0.50) P4HTMNPC1RAB9ASMN1; SMN2GABRA5
SCHEMBL7871609 0.85 P4HTM (0.55) P4HTMGABRA5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed